A Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
Clinical trial NCT06540833 · RECRUITING
Trial details
- NCT number
- NCT06540833
- Sponsor
- Intra-Cellular Therapies, Inc.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-15
- Primary completion
- 2028-09-30
- Enrollment
- 370
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.